Pfizer Inc. said it halted one of four late-stage studies for the kidney cancer drug Sutent in patients with advanced breast cancer.

Pfizer Inc. said it halted one of four late-stage studies for the kidney cancer drug Sutent in patients with advanced breast cancer.